DNA CIK: 1830214

Ginkgo Bioworks Holdings, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY22
billions USD
FY21:
0.18
FY22:
0.27
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
billions USD
FY21:
−1.96
FY22:
−2.41
FY23:
−0.86
FY24:
−0.56
FY25:
−0.32
(positive)
Change from FY21 to FY22
billions USD
FY21:
−1.88
FY22:
−2.18
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
billions USD
FY21:
−1.84
FY22:
−2.12
FY23:
−0.89
FY24:
−0.55
FY25:
−0.31
(positive)
Change from FY21 to FY25
billions USD
FY21:
−1.83
FY22:
−2.10
FY23:
−0.89
FY24:
−0.55
FY25:
−0.31

All amounts in billions USD Data sources:SEC EDGARTwelve Data